Authors:
McLellan, AD
Terbeck, G
Mengling, T
Starling, GC
Kiener, PA
Gold, R
Brocker, EB
Leverkus, M
Kampgen, E
Citation: Ad. Mclellan et al., Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development, CELL DEAT D, 7(10), 2000, pp. 933-938
Authors:
Dopp, R
Schmidt, E
Chimanovitch, I
Leverkus, M
Brocker, EB
Zillikens, D
Citation: R. Dopp et al., IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid: Serum levels of these immunoglobulins reflect disease activity, J AM ACAD D, 42(4), 2000, pp. 577-583
Authors:
Leverkus, M
Neumann, M
Mengling, T
Rauch, CT
Brocker, EB
Krammer, PH
Walczak, H
Citation: M. Leverkus et al., Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes, CANCER RES, 60(3), 2000, pp. 553-559
Authors:
Leverkus, M
Walczak, H
McLellan, A
Fries, HW
Terbeck, G
Brocker, EB
Kampgen, E
Citation: M. Leverkus et al., Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis, BLOOD, 96(7), 2000, pp. 2628-2631
Citation: M. Leverkus et al., Intertriginous acantholytic dyskeratosis: abortive form of Darier disease or a specific entity?, HAUTARZT, 50(10), 1999, pp. 733
Authors:
Leverkus, M
Schmidt, E
Lazarova, Z
Brocker, EB
Yancey, KB
Zillikens, D
Citation: M. Leverkus et al., Antiepiligrin cicatricial pemphigoid - An underdiagnosed entity within thespectrum of scarring autoimmune subepidermal bullous diseases?, ARCH DERMAT, 135(9), 1999, pp. 1091-1098